Rafarma update

Dear Rafarma shareholders,

We apologize for the delay in providing information about the company's activities in recent months. The past months have been truly transformational for us. And the company transformations that we are going through now will bring a long-awaited update for the company in the new year. “Everything that does not kill us makes us stronger,” said the German philosopher Nietzsche back in the 19th century. This is how we approach business challenges in the 21st century. We will hold a press conference for you in March 2025 to share the news that we have been preparing since autumn 2024 regarding the company's structure, audit and its new pharmaceutical areas. We need to make a number of changes before March 2025 so that we can please you with facts. We need this time for this. The best lawyers and financiers are working with us. Our press attaché Liza Babenko will collect all your questions by that time and we will voice over them at the press conference. Please contact her with questions before that time.

Sincerely,

Chairman of the Board of Directors of Rafarma

Ilya Shpurov